JanOne (NASDAQ: JAN) is a pharmaceutical company dedicated to developing innovative treatments for chronic diseases. With a focus on improving the lives of individuals suffering from conditions such as non-alcoholic steatohepatitis (NASH) and other metabolic disorders, JanOne is committed to advancing medical solutions that address unmet needs in the healthcare industry. Through cutting-edge research and a patient-centric approach, JanOne is at the forefront of transforming the landscape of chronic disease management.

Refer new talent to Janone